Otsuka Secures Global Licensing for FUS-ALS Treatment from Ionis
Orion’s Virtakoivu Advances Cancer Treatment Through Immune Activation
Texas Launches Innovative HPV Self-Screening Pilot to Boost Cervical Cancer Detection
Jazz Pharma Secures FDA Nod for Ziihera in HER2+ Biliary Tract Cancer
Early Colon Cancer Screening Lacks Clear Protocols for High-Risk Under-50s
Johnson & Johnson Highlights Expansive Hematology Innovations at ASH 2024
Abbott Boosts Clinical Trial Diversity Through Strategic Partnerships and New Initiatives
Dapirolizumab Pegol Boosts Lupus Treatment Efficacy in Phase 3 Study
J&J Introduces Yuvanci Tablets to Combat Pulmonary Hypertension
Melt Pharmaceuticals Achieves Successful Phase 3 Results for MELT-300 in Cataract Surgery Sedation
GSK’s Linerixibat Significantly Reduces Itching in PBC Patients in Phase III Trial
Pliant Therapies Unveils Promising PSC Treatment Results at Liver Meeting 2024
FDA Seeks Labeling Clarifications Before Approving IZERVAY’s Supplemental Application
Incyte Pauses Phase 2 MRGPRX2 Trial After Toxicity Concerns
Icotrokinra Delivers Superior Skin Clearance in Phase 3 Psoriasis Study